Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Long-Term Outcomes of Chronic Myeloid Leukemia Patients Who Lost Undetectable Molecular Residual Disease (UMRD) after Imatinib Discontinuation: Korean Imatinib Discontinuation Study (KIDS)

Sung-Eun Lee, MD, Joon Seong Park, MD, Hyeoung-Joon Kim, MD PhD, Sung-Hyun Kim, MD PhD, Dae Young Zang, MD PhD, Sukjoong Oh, MD PhD, Young Rok Do, PhDMD, Yunsuk Choi, MD, Jae-Yong Kwak, MD PhD, Jeong-A Kim, MD PhD, Kyoo Hyung Lee, MD PhD, Yeung-Chul Mun, MD, Won Sik Lee, MD PhD, Myung Hee Chang, MD, Jinny Park, MD PhD, Jihyun Kwon, MD, Dong-Wook Kim

Blood (2019) 134 (Supplement_1): 1643.

https://doi.org/10.1182/blood-2019-126376

Published: 2019

Journal Articles

Final Study Results of Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 48 Months Follow-up

Blood (2018) 132 (Supplement 1): 1733.

https://doi.org/10.1182/blood-2018-99-110568

Published: 2018

Journal Articles

Pigment Epithelium-Derived Factor Promotes the Angiogenic Activity of VEGF

Jeong-A Kim, MD PhD, Misuk Yang, Young Hoon Park, MD, Youngrok Park, Jae-Yong Kwak, MD PhD

Blood (2018) 132 (Supplement 1): 3687.

https://doi.org/10.1182/blood-2018-99-117420

Published: 2018

Journal Articles

Fractalkine/CX3CR1 Signaling Promotes Angiogenic Potentials in CX3CR1 Expressing Monocytes

Jeong A Kim, MD PhD, Jae-Yong Kwak, MD PhD, Yhim Eunjung, MD, Joon Lee, Youngrok Park, Hal E. Broxmeyer, PhD

Blood (2016) 128 (22): 2507.

https://doi.org/10.1182/blood.V128.22.2507.2507

Published: 2016

Journal Articles

Comparable Outcomes with Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients with or without Aplastic Anemia in a Prospective Korean PNH Registry

Jun Ho Jang, Jin Seok Kim, MD PhD, Deog-Yeon Jo, MD PhD, Je-Hwan Lee, MD PhD, Chul Won Choi, MD PhD, Hyeoung Joon Kim, MD PhD, Jong-Ho Won, MD PhD, Joo Seop Chung, MD PhD, Hawk Kim, MD PhD, Jae-Hoon Lee, MD PhD, Sang Kyun Sohn, MD PhD, Jeong A Kim, MD PhD, Jong Wook Lee, MD PhD

Blood (2015) 126 (23): 4789.

https://doi.org/10.1182/blood.V126.23.4789.4789

Published: 2015

Journal Articles

Results from the Korean Imatinib Discontinuation Study (KIDS): Updated Data with 15-Month Median Follow up

Blood (2014) 124 (21): 3155.

https://doi.org/10.1182/blood.V124.21.3155.3155

Published: 2014

Journal Articles

The Role of CD11b+CX3CR1+ Cells in Neovascularization

Jeong-A Kim, MD PhD, Jae-Yong Kwak, MD PhD, Kyoungmi Noh, Joon Lee, Youngrok Park, Hal E. Broxmeyer, PhD

Blood (2014) 124 (21): 4180.

https://doi.org/10.1182/blood.V124.21.4180.4180

Published: 2014

Journal Articles

Long-Term Follow-up Results after Imatinib Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease

Ho-Young Yhim, MD PhD, Na Ri Lee, MD PhD, Eun-Kee Song, MD PhD, Chang-Yeol Yim, MD PhD, So Yeon Jeon, MD, Bohee Lee, MD, Jeong-A Kim, MD PhD, Hee Sun Kim, Eun Hae Cho, Jae-Yong Kwak, MD PhD

Blood (2014) 124 (21): 4553.

https://doi.org/10.1182/blood.V124.21.4553.4553

Published: 2014

Journal Articles

Clinical Outcomes of R-CHOP Chemotherapy Alone Compared with R-CHOP Plus Radiotherapy in Patients with Localized, Non-Bulky Diffuse Large B-Cell Lymphoma

Blood (2014) 124 (21): 4421.

https://doi.org/10.1182/blood.V124.21.4421.4421

Published: 2014

Journal Articles

Ineffective Corticosteroid Treatment for Hemolysis Management of Paroxysmal Nocturnal Hemoglobinuria

Jong Wook Lee, MD PhD, Jun Ho Jang, MD PhD, Je-Hwan Lee, MD PhD, Deog-Yeon Jo, MD PhD, Jin Seok Kim, Yong Park, MD PhD, Sang Kyun Sohn, MD PhD, Jun Sung Park, MD PhD, Chul Won Choi, MD PhD, Joo Seop Chung, MD PhD, Jae Hoon Lee, MD PhD, Jeong A Kim, MD PhD, Jong-Ho Won, MD PhD

Blood (2014) 124 (21): 5151.

https://doi.org/10.1182/blood.V124.21.5151.5151

Published: 2014

Journal Articles

Interim Positron Emission Tomography Scan Predicts Early Outcomes Of Patients With Peripheral T-Cell Lymphoma

Ho-Young Yhim, MD, Na-Ri Lee, Eun-Kee Song, So Yeon Jeon, Chang-Yeol Yim, Yeon-Hee Han, Myung-Hee Sohn, Bohee Lee, MD, Jeong-A Kim, MD, PhD, Young Ha Park, Woo Hee Choi, Hee Sun Kim, Jae-Yong Kwak

Blood (2013) 122 (21): 4364.

https://doi.org/10.1182/blood.V122.21.4364.4364

Published: 2013

Journal Articles

Clinical Signs and Symptoms In Non-Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria From a Korean Prospective PNH Registry

Jong Wook Lee, MD, PhD, Jun Ho Jang, MD, PhD, Jin Seok Kim, MD, Je-Hwan Lee, Deog-Yeon Jo, MD, PhD, Yeo-Kyeoung Kim, MD, PhD, Jooseop Chung, MD, PhD, Jeong-A Kim, MD, PhD, Jae Hoon Lee, Chul-Won Choi, MD, PhD, Yong Park, MD, PhD, Jun Sung Park, MD, PhD

Blood (2013) 122 (21): 3720.

https://doi.org/10.1182/blood.V122.21.3720.3720

Published: 2013

Journal Articles

Response Adapted Lenalidomide Based Therapy For Newly Diagnosed (ND) Standard Risk Older Adults With Multiple Myeloma (MM): An International Collaboration

Rachid Baz, MD, Hui-Yi Lin, PhD, Sung-Soo Yoon, MD, Kihyun Kim, MD, Melissa Alsina, MD, Kenneth H. Shain, MD, PhD, Dan Sullivan, MD, Hye Jin Kang, Jin Seok Kim, MD, Cheolwon Suh, Je-Jung Lee, MD, PhD, Jeong-A Kim, MD, PhD, Yang Soo Kim, MD, Chang-Ki Min, MD, Jae-Yong Kwak, MD, PhD, Sung-Hyun Kim, MD, PhD, Won Sik Lee, MD, Junshik Hong, MD, Jae Hoon Lee, MD

Blood (2013) 122 (21): 3201.

https://doi.org/10.1182/blood.V122.21.3201.3201

Published: 2013

Journal Articles

The Role Of CD11b+CX3CR1+ Cells In Neovascularization

Jeong-A Kim, MD, PhD, Jae-Yong Kwak, MD, PhD, Kyoungmi Noh, Hyun-Kyung Kim, PhD, Bohee Lee, MD, Youngrok Park, Young June Kim, PhD, Hal E. Broxmeyer, PhD

Blood (2013) 122 (21): 2301.

https://doi.org/10.1182/blood.V122.21.2301.2301

Published: 2013

Journal Articles

Results From The Korean Imatinib Discontinuation Study (KIDS): Updated Data With 14-Month Median Follow Up

Blood (2013) 122 (21): 4003.

https://doi.org/10.1182/blood.V122.21.4003.4003

Published: 2013

Journal Articles

Astrocyte-Plexus Is Formed in the Neovascularization Induced by CD11b+ Cells From An Ischemic Hind-Limb Mouse Model.

Jeong A. Kim, MD, PhD., Oak Kee Hong, PhD, Jong Wook Hong, Hal E. Broxmeyer, PhD

Blood (2009) 114 (22): 3043.

https://doi.org/10.1182/blood.V114.22.3043.3043

Published: 2009

Journal Articles

Purified Gr1+CD11b+ Cells Induce Neovascularization in An Ischemic Hind Limb Mouse Model.

Jeong A Kim, MD, PhD, Keith March, MD, PhD, Heedon Chae, PhD, Brian Johnstone, PhD, Todd Cook, BSc, Stephanie Merfeld-Clauss, BSc, Hal E. Broxmeyer, PhD

Blood (2008) 112 (11): 1894.

https://doi.org/10.1182/blood.V112.11.1894.1894

Published: 2008

Journal Articles

A Report of AIDS-Related Lymphoma (ARL) in Korea.

Jin-Soo Kim, MD, Seok Jin Kim, MD, Jin Seok Kim, MD, Yoo Hong Min, MD, Moon Hee Lee, MD, Soo-Mee Bang, MD, Jeong A. Kim, MD, Hyun-Sook Chi, MD, Seong Soo Jang, MD, Chan Jeoung Park, MD, Cheolwon Suh, MD, Chul Soo Kim, MD

Blood (2006) 108 (11): 4687.

https://doi.org/10.1182/blood.V108.11.4687.4687

Published: 2006

Journal Articles

Mobilization of Stem Cells from the Bone Marrow Is Required for Neovascularization of Ischemic Limbs in Mice.

Jeong-A Kim, MD, Chang -Hoon Lee, Ms, Jin-A. Yoon, BS, Woo-Sung Min, MD, Chun-Choo Kim, MD

Blood (2005) 106 (11): 4233.

https://doi.org/10.1182/blood.V106.11.4233.4233

Published: 2005

Journal Articles

The Arrest of Cell Cycle Progression in Mixed Lymphocyte Reaction by Cultured Mouse Mesenchymal Stem Cell.

Jeong-A. Kim, MD, Sungyoul Hong, Ph.D

Blood (2004) 104 (11): 4956.

https://doi.org/10.1182/blood.V104.11.4956.4956

Published: 2004

NARROW

Long-Term Outcomes of Chronic Myeloid Leukemia Patients Who Lost Undetectable Molecular Residual Disease (UMRD) after Imatinib Discontinuation: Korean Imatinib Discontinuation Study (KIDS)

Final Study Results of Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 48 Months Follow-up

Pigment Epithelium-Derived Factor Promotes the Angiogenic Activity of VEGF

Fractalkine/CX3CR1 Signaling Promotes Angiogenic Potentials in CX3CR1 Expressing Monocytes

Comparable Outcomes with Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients with or without Aplastic Anemia in a Prospective Korean PNH Registry

Results from the Korean Imatinib Discontinuation Study (KIDS): Updated Data with 15-Month Median Follow up

The Role of CD11b+CX3CR1+ Cells in Neovascularization

Long-Term Follow-up Results after Imatinib Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease

Clinical Outcomes of R-CHOP Chemotherapy Alone Compared with R-CHOP Plus Radiotherapy in Patients with Localized, Non-Bulky Diffuse Large B-Cell Lymphoma

Ineffective Corticosteroid Treatment for Hemolysis Management of Paroxysmal Nocturnal Hemoglobinuria

Interim Positron Emission Tomography Scan Predicts Early Outcomes Of Patients With Peripheral T-Cell Lymphoma

Clinical Signs and Symptoms In Non-Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria From a Korean Prospective PNH Registry

Response Adapted Lenalidomide Based Therapy For Newly Diagnosed (ND) Standard Risk Older Adults With Multiple Myeloma (MM): An International Collaboration

The Role Of CD11b+CX3CR1+ Cells In Neovascularization

Results From The Korean Imatinib Discontinuation Study (KIDS): Updated Data With 14-Month Median Follow Up

Astrocyte-Plexus Is Formed in the Neovascularization Induced by CD11b+ Cells From An Ischemic Hind-Limb Mouse Model.

Purified Gr1+CD11b+ Cells Induce Neovascularization in An Ischemic Hind Limb Mouse Model.

A Report of AIDS-Related Lymphoma (ARL) in Korea.

Mobilization of Stem Cells from the Bone Marrow Is Required for Neovascularization of Ischemic Limbs in Mice.

The Arrest of Cell Cycle Progression in Mixed Lymphocyte Reaction by Cultured Mouse Mesenchymal Stem Cell.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only